Cilostazol attenuates 4-hydroxynonenal-enhanced cd36 expression on murine macrophages via inhibition of nadph oxidase-derived reactive oxygen species production

Korean Journal of Physiology and Pharmacology

Volumn 13, Issue 2, 2009, Pages 99-106

  Yun, Mi Ran ^a,b   Park, Hye Mi ^a,b   Seo, Kyo Won ^a,b   Kim, Chae Eun ^a,b   Yoon, Jung Wook ^a,b   Kim, Chi Dae ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

CD36; Cilostazol; HNE; NADPH oxidase

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 4 HYDROXYNONENAL; ACETYLCYSTEINE; APOCYNIN; CD36 ANTIGEN; CILOSTAZOL; ENZYME INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; CELL STIMULATION; CELL STRESS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; LIPID PEROXIDATION; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION;

EID: 67649383504     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2009.13.2.99     Document Type: Article

References (37)

1. Amer J, Goldfarb A, Fibadi E. Flowcytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 70: 84- 90, 2003.
2. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer EL, Edwards PA, Watson, AD, Lusis AJ. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488-2496, 1995.
3. Cevik MO, Katsuyama M, Kanda 5, Kaneko T, Iwata K, Ibi M, Matsua K, Kakehi T, Cui W, Sasalci M, Yahe-Nishimura C. The .AP-1 site is essential for the promoter activity of NOX1INADPH oxidase. a vascular superoxide-producing enzyme: Possible iovolvement of the ERK1/2-JunB pathway. Biochem Biophys Res Commun 379: 351-355, 2008.
4. Esterbauer H, Sohaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128, 1991.
5. Forman HJ, Fukuto JM, Miller T, Zhang H, Rinna A, Levy S. The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch Biochem Biophys 477: 183- 195, 2008.
6. Funk CD. Prostaglandins and leukotrienes: advaoces in eicosanoid biology. Science 294: 1871-1875, 2001.
7. Greaves DR, Gesxkn S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res 46: 11- 20, 2005.
8. Han J, Hajjar DP, Febbraio M, Nididsesi AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor. J Biol Chen 272: 21645-21659, 1997.
9. Ishli T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, Mann GE. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified fADE and 4-hydroxynonenal. Circ Res 94: 609 616, 2004.
10. Katsuyaxna M, Ozgur CM, Arakawa N, Kakehi T, Nishinaka T, Iwata K, Ibi M, Matsuno K, Yabe-Nishimura C. Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS J 274: 5128-5136, 2007.
11. Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneirnittelforschung 35: 1144-1149, 1985.
12. Knöbel Y, Glel M, Osswald K, Pool-Zobel BL Ferric iron increases ROS formation, modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cells. Toxicol In Vitro 20: 793 800, 2006.
13. Kumagai T, Matsukawa N, Kaneko Y, Kusumi Y, Mitsumata M, Udilda K. A lipid peroxidation-derived inflammatory mediator: identification of 4-bydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chen 279: 48389-48396, 2004.
14. Lee JH, Oh GT, Park SY, Choi JH, Park JG, Khn CD, Lee WS, Rhim BY, Shin 1W, Hong KW. Ciostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-formation in low-density lipoprotein receptor-null mice fed high cholesterol. J Pharmacol Exp Ther 313: 502-509, 2005.
15. Lee JY, Jung GY, Heo HJ, Yun MR, Park JY, Bee SS, Hong KW, Lee WS, Kim CD. 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol Lett 166: 212 221, 2006.
16. Leonarduzzi G, Chiarpotto K, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 49: 1044-1049, 2005.
17. Manea A, Manea SA, Gafenai AV, Rains M. Regulation of NADPH oxidase subunit p22 (phox) by NF-kB in human aortic smooth muscle cells. Arch Physiol Biochem 113: 163 172, 2007.
18. Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26: 1702 1711, 2006.
19. Nakata A, Nalcagawa Y, Nishida M, Nozaki 5, Miyagawa J, Nakagawa T, Tamura R, Matsumoto K, Kameda-Takemura K, Yamashita 5, Matsuzawa Y. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol 19: 1333 1339, 1999.
20. Okutsu R, Yoshikawa T, Nagasawa M, Himse Y, Takase H, Mitani K, Okada K, Miyakoda C, Yabuuchi V. Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages. Atherosclerosis 2008 Nov 17. [Epub ahead of print].
21. Peters-Golden M, Brook TG. 5-lipoxygenase and FLAP. Prostaglandins Leukot Essent Fatty Acids 69: 99-109, 2003.
22. Raza H, John A. 4-hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Appl Pharmacol 216: 309-318, 2006.
23. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138: S419 5420, 1999.
24. Samuelsson B, Dahlen SE, Lindgren JA, Rouser CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176, 1987.
25. Sampey BP, Carhone DL, Dorn JA, Petersen DR. 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-i-activating protein-i signal transduction. Mol Pharmocol 71: 871 - 883, 2007.
26. Serezani CH, Aronnof DM, Jancar S, Peters-Golden M. Leukotriene B4 mediates p47phox phosphorylation and membrane translocation in polyunsaturated fatty acid-stimulated neutrophils. J Leukoc Biol 78: 976-984, 2005.
27. Serezani CH, Aronoff DM, Jancnr S, Mancuso P, Peters-Golden M. Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 106: 1067-1075, 2005.
28. Shimizu T, Radmark 0, Samuelsson B. Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid. Proc Natl Acad Sci USA 81: 689-693, 1984.
29. Shin HK, Kim YK, Kim KY, Lee JH, Hong KW. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-i activation: Prevention by cilostazol. Circulation 109: 1022- 1028, 2004.
30. Stocker R Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381 -1478, 2004.
31. Thannidcal VJ, Fanburg BL Reactive oxygen species in cell signaling. Am J Fhysiol Lung Cell Mol Physiol 279: L1005 - 1028, 2000.
32. Udiida K. 4-Hyclroxy-2-nonenal: a product and mediator of oxidative stress. Frog Lipid Res 42: 318-343, 2003.
33. Woo CH, You HJ, Cho SH. Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J Biol Chem 277: 8572-8578, 2002.
34. Yesner LM, Huh HY, Pearce SF, Siverstein RL Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Bid 16: 1019-1025, 1996.
35. Yoshida H, Quehenbeiwer 0, Kondratenko N, Green 5, Steinberg D. Minimaily oxidized low-density lipoproteinincreases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophagea. Arterioacler Thromb Vasc Biol 18: 794 802, 1998.
36. Yun MR, Tm US, Lee SJ, Woo JW, Hong KW, Bee SS, Kim CD. 4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class a scavenger receptor at the level of translation. Free Radic Bid Med 45: 177-183, 2008.
37. Yun MR, Tm US, Lee SJ, Park HZ Bee 55, Lee WS, Kim CD. 4-Hydroxynonenal enhances CD36 expression on murine macropbages via p38 IVIAPK-mediated activation of 5-lipoxy- genase. Free Rodic Bid Med 46: 692-698, 2009.